DNA-shredding CRISPR enzyme targets cancer cells

Researchers have developed a CRISPR enzyme that shreds DNA and is being tested against cancer cells. This approach could offer a new way to selectively destroy tumors while sparing healthy tissue, representing a promising advance in cancer therapy.

Sources (1)